243 related items for PubMed ID: 20442650
21. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
[Abstract] [Full Text] [Related]
22. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ, Wetzels JF.
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[Abstract] [Full Text] [Related]
23. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
Fervenza FC, Canetta PA, Barbour SJ, Lafayette RA, Rovin BH, Aslam N, Hladunewich MA, Irazabal MV, Sethi S, Gipson DS, Reich HN, Brenchley P, Kretzler M, Radhakrishnan J, Hebert LA, Gipson PE, Thomas LF, McCarthy ET, Appel GB, Jefferson JA, Eirin A, Lieske JC, Hogan MC, Greene EL, Dillon JJ, Leung N, Sedor JR, Rizk DV, Blumenthal SS, Lasic LB, Juncos LA, Green DF, Simon J, Sussman AN, Philibert D, Cattran DC, Mentor Consortium group.
Nephron; 2015 Jul; 130(3):159-68. PubMed ID: 26087670
[Abstract] [Full Text] [Related]
24. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
Goumenos DS, Kalliakmani P, Tsakas S, Sotsiou F, Vlachojannis JG.
Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453
[Abstract] [Full Text] [Related]
25. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[Abstract] [Full Text] [Related]
26. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Hoyer PF, Brodeh J.
J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
[Abstract] [Full Text] [Related]
27. Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety.
Yu X, Ruan L, Qu Z, Cui Z, Zhang Y, Wang X, Meng L, Liu X, Wang F, Zhang Y, Liu G, Yang L.
Ren Fail; 2017 Nov; 39(1):688-697. PubMed ID: 28882100
[Abstract] [Full Text] [Related]
28. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
Li X, Lv R, He Q, Li H, Du X, Lin W, Li Q, He X, Wang S, Chen J.
J Nephrol; 2008 Nov; 21(4):584-91. PubMed ID: 18651550
[Abstract] [Full Text] [Related]
29. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
Frassinetti Castelo Branco Camurça Fernandes P, Bezerra Da Silva G, De Sousa Barros FA, Costa Oliveira CM, Kubrusly M, Evangelista JB.
J Nephrol; 2005 Nov; 18(6):711-20. PubMed ID: 16358229
[Abstract] [Full Text] [Related]
30. [Steroid and cyclosporine therapy in idiopathic membranous nephropathy: monocentric experience and literature review].
Zotta F, Di Stasio E, Manzione A, Pirozzi N, Stoppacciaro A, Menè P.
G Ital Nefrol; 2019 Jun 11; 36(3):. PubMed ID: 31251003
[Abstract] [Full Text] [Related]
31. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
Boumpas DT, Tassiulas IO, Fleisher TA, Vaughan E, Piscitelli S, Kim Y, Pucino F, Balow JE, Austin HA.
Clin Nephrol; 1999 Aug 11; 52(2):67-75. PubMed ID: 10480216
[Abstract] [Full Text] [Related]
32. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW, Wetzels JF.
Nephrol Dial Transplant; 2004 Aug 11; 19(8):2036-43. PubMed ID: 15187191
[Abstract] [Full Text] [Related]
33. Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy.
Kalliakmani P, Koutroulia E, Sotsiou F, Vlachojannis JG, Goumenos DS.
Nephrology (Carlton); 2010 Dec 11; 15(8):762-7. PubMed ID: 21175962
[Abstract] [Full Text] [Related]
34. Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis.
Liu D, Yang Y, Kuang F, Qing S, Hu B, Yu X.
Int Immunopharmacol; 2019 May 11; 70():354-361. PubMed ID: 30852290
[Abstract] [Full Text] [Related]
35. Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial.
Chen Y, Deng Y, Ni Z, Chen N, Chen X, Shi W, Zhan Y, Yuan F, Deng W, Zhong Y.
Am J Kidney Dis; 2013 Dec 11; 62(6):1068-76. PubMed ID: 23810688
[Abstract] [Full Text] [Related]
36. [Long-term effects of cyclosporine A in children with steroid-resistant idiopathic nephrotic syndrome and outcomes of the patients].
Cao Q, Huang WY, Xu H, Zhou LJ.
Zhonghua Er Ke Za Zhi; 2008 Sep 11; 46(9):698-701. PubMed ID: 19099862
[Abstract] [Full Text] [Related]
37. Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome.
Yuan H, Liu N, Sun GD, Jia Y, Luo P, Miao LN.
Pharmacology; 2013 Sep 11; 91(5-6):259-66. PubMed ID: 23652322
[Abstract] [Full Text] [Related]
38. Efficacy and safety of rituximab second-line therapy for membranous nephropathy: a prospective, matched-cohort study.
Cravedi P, Sghirlanzoni MC, Marasà M, Salerno A, Remuzzi G, Ruggenenti P.
Am J Nephrol; 2011 Sep 11; 33(5):461-8. PubMed ID: 21508634
[Abstract] [Full Text] [Related]
39. Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.
Cortazar FB, Leaf DE, Owens CT, Laliberte K, Pendergraft WF, Niles JL.
BMC Nephrol; 2017 Feb 01; 18(1):44. PubMed ID: 28143416
[Abstract] [Full Text] [Related]
40. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
Ren S, Wang Y, Xian L, Toyama T, Jardine M, Li G, Perkovic V, Hong D.
PLoS One; 2017 Feb 01; 12(9):e0184398. PubMed ID: 28898290
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
